July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Systemic inflammation in a collagen-induced arthritis mouse model of rheumatoid arthritis leads to attenuated laser-induced choroidal neovascularization
Author Affiliations & Notes
  • Gloriane Schnabolk
    Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, United States
  • Elisabeth Obert
    Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, United States
  • Nirmal K. Banda
    Division of Rheumatology, University of Colorad Anschutz Medical Campus, Aurora, Colorado, United States
  • Baerbel Rohrer
    Department of Ophthalmology, Medical University of South Carolina, Charleston, South Carolina, United States
    Division of Research, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States
  • Footnotes
    Commercial Relationships   Gloriane Schnabolk, None; Elisabeth Obert, None; Nirmal Banda, None; Baerbel Rohrer, None
  • Footnotes
    Support  NIH K12HD055885
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5559. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gloriane Schnabolk, Elisabeth Obert, Nirmal K. Banda, Baerbel Rohrer; Systemic inflammation in a collagen-induced arthritis mouse model of rheumatoid arthritis leads to attenuated laser-induced choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5559.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Age-related macular degeneration (AMD) is the leading cause of blindness among the elderly in the U.S. Current research suggests that AMD is characterized by inflammation and deregulation of the complement cascade, as well as oxidative stress and cytokine response. These characteristics are also present in rheumatoid arthritis (RA), a painful disease resulting in inflammation of the joints. While AMD shares similarities with RA, the role of a secondary inflammatory disease on AMD pathogenesis is largely unknown. Using mouse models, this study investigates the role of RA on laser induced choroidal neovascularization (CNV), a model for wet AMD.

Methods : Collagen-induced arthritis (CIA) was induced in C57BL/6J mice by immunization with collagen type II in adjuvant followed by induction of CNV at the peak of disease. CNV lesion size was quantified using optical coherence photography (OCT). Functional differences between CIA and control mice in the absence and presence of CNV was analyzed using optokinetic response (OKR) to measure spatial acuity and contrast sensitivity, as well as full-field electroretinography (ERG) to examine retina and RPE function.

Results : OKR analysis of CIA mice compared to controls indicated a significant decrease in both spatial acuity (control: 0.37 ± 0.009; CIA: 0.32 ± 0.011: p ≤ 0.01) as well as contrast sensitivity (control: 5.85 ± 0.63; CIA: 2.99 ± 0.38; p ≤ 0.001), whereas no differences were observed for a-, b- and c-wave analyses. Surprisingly, systemic inflammation caused by CIA resulted in significantly reduced CNV lesion size (control: 8530 ± 496.3µm2; CIA: 5961 ± 481.9 µm2; p ≤ 0.001). Functional differences after CNV are forthcoming.

Conclusions : Our data demonstrated that increased systemic inflammation caused by CIA reduced both spatial acuity and contrast sensitivity, features that assess ocular and CNS function, whereas the purely retinal or RPE readouts (ERG) were unaffected. CIA was observed to attenuate CNV lesion size, suggesting that despite sharing similarities in etiology, CIA and CNV were not additive. It will be of great interest to determine whether RA reduces the risk of developing wet AMD in patients. Finally, these results highlight the need to further investigate the impact of a secondary inflammatory disease on wet and dry AMD.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×